|

[203Pb]VMT01 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Perspective Therapeutics1

Indications

  • Recurrent Melanoma (Skin)1
  • Melanoma Stage III1
  • Melanoma Stage IV1
  • Metastatic Melanoma1
  • Cancer1

Orange, California1 trial

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

University of California Irvine

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.